Top compounds associated with response to CEP89


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.011 0.8
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.8
mRNA TKI258 CCLE pan-cancer AAC 0.015 0.8
mRNA BRD1812 CTRPv2 pan-cancer AAC -0.011 0.8
mRNA Bexarotene CTRPv2 pan-cancer AAC -0.011 0.8
mRNA Cyclopamine GDSC1000 pan-cancer AAC 0.017 0.8
mRNA dabrafenib CTRPv2 pan-cancer AAC -0.015 0.8
mRNA Vinorelbine GDSC1000 pan-cancer AAC 0.01 0.8
mRNA A-443654 GDSC1000 pan-cancer AAC -0.016 0.8
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC 0.0098 0.8
Download CSV